Stock DNA
Other Agricultural Products
USD 25 Million ()
NA (Loss Making)
NA
0.00%
-11.40
409.49%
-4.29
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Sep 2024)
Net Profit:
-12 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-33.33%
0%
-33.33%
6 Months
-20.0%
0%
-20.0%
1 Year
-60.0%
0%
-60.0%
2 Years
-60.0%
0%
-60.0%
3 Years
-78.95%
0%
-78.95%
4 Years
-94.59%
0%
-94.59%
5 Years
-91.3%
0%
-91.3%
Cansortium, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
34.23%
EBIT Growth (5y)
17.52%
EBIT to Interest (avg)
-0.23
Debt to EBITDA (avg)
6.38
Net Debt to Equity (avg)
-11.40
Sales to Capital Employed (avg)
1.17
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
14.24%
ROE (avg)
9.70%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-5.46
EV to EBIT
10.93
EV to EBITDA
4.04
EV to Capital Employed
1.62
EV to Sales
0.93
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.83%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bearish
Bearish
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY
Sep'24
Sep'23
Change(%)
Net Sales
26.10
25.30
3.16%
Operating Profit (PBDIT) excl Other Income
4.40
11.10
-60.36%
Interest
5.20
4.60
13.04%
Exceptional Items
0.30
-3.90
107.69%
Consolidate Net Profit
-11.80
-5.30
-122.64%
Operating Profit Margin (Excl OI)
17.80%
311.00%
-29.32%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2024 is 3.16% vs 14.48% in Sep 2023
Consolidated Net Profit
YoY Growth in quarter ended Sep 2024 is -122.64% vs 5.36% in Sep 2023
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
97.30
87.70
10.95%
Operating Profit (PBDIT) excl Other Income
38.80
27.20
42.65%
Interest
18.00
16.20
11.11%
Exceptional Items
-15.10
-23.50
35.74%
Consolidate Net Profit
-22.70
-37.10
38.81%
Operating Profit Margin (Excl OI)
243.90%
153.70%
9.02%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 10.95% vs 34.10% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 38.81% vs -95.26% in Dec 2022
About Cansortium, Inc. 
Cansortium, Inc.
Other Agricultural Products
Cansortium Inc. operates an industrial hemp production in Canada. The Company produces and sells medical cannabis in Florida, Texas and Pennsylvania. The Company also operates as a seed bank and sells medical cannabis in Colombia. The Company operates under Fluent brand. Through its subsidiaries, the Company operates cultivation, processing and dispensary facilities. The Company’s medical cannabis products are offered in oral drops, capsules, suppositories, topicals, syringes, dried flower, prerolls and cartridges. Its subsidiaries include Cansortium Pennsylvania, LLC, Cansortium Texas, LLC, Cansortium Canada Holdings Inc., Cansortium Canada Servicing, Inc. and Cansortium Florida, LLC.
Company Coordinates 
Company Details
82 NE 26th St Unit 110 , MIAMI FL : 33137-4442
Registrar Details






